New booster shot shows promise for vulnerable patients
NCT ID NCT06027229
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 26 times
Summary
This study looked at whether a recombinant COVID-19 booster vaccine can strengthen immune protection in people with weakened immune systems, specifically those with inflammatory bowel disease or who have had an organ transplant. 21 participants received the booster and were followed for 6 months. The goal was to measure antibody levels and immune cell responses after vaccination.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UW School of Medicine and Public Health
Madison, Wisconsin, 53792, United States
Conditions
Explore the condition pages connected to this study.